Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: Results from a 10 -year prospective community study

American Journal of Psychiatry

Volumn 168, Issue 10, 2011, Pages 1107-1116

  Zimmermann, Petra ^a,b,c   Brückl, Tanja ^a,b,c   Nocon, Agnes ^a,b,c   Pfister, Hildegard ^a,b,c   Binder, Elisabeth B ^a,b,c   Uhr, Manfred ^a,b,c   Lieb, Roselind ^a,b,c   Moffitt, Terrie E ^a,b,c   Caspi, Avshalom ^a,b,c   Holsboer, Florian ^a,b,c   Ising, Marcus ^a,b,c  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b DUKE UNIVERSITY   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CAUCASIAN; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FKBP5 GENE; FOLLOW UP; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MOLECULAR GENETICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

EID: 80054814012     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.10111577     Document Type: Article

References (45)

1. Plomin R, DeFries JC, Loehlin JC: Genotype-environment interaction and correlation in the analysis of human behavior. Psychol Bull 1977; 84:309-322
2. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301:386-389 (Pubitemid 36877077)
3. Holsboer F: The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000; 23:477-501
4. Heim C, Plotsky PM, Nemeroff CB: Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology 2004; 29:641-648 (Pubitemid 38402471)
5. Lupien SJ, McEwen BS, Gunnar MR, Heim C: Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009; 10:283-294
6. Denny WB, Valentine DL, Reynolds PD, Smith DF, Scammell JG: Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology 2000; 141:4107-4113
7. Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, Rein T: FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 2005; 280:4609-4616 (Pubitemid 40288629)
8. Vermeer H, Hendriks-Stegeman BI, van der Burg B, van Buul-Offers SC, Jansen M: Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab 2003; 88:277-284 (Pubitemid 36115178)
9. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B, Papiol S, Seaman S, Lucae S, Kohli MA, Nickel T, Künzel HE, Fuchs B, Majer M, Pfennig A, Kern N, Brunner J, Modell S, Baghai T, Deiml T, Zill P, Bondy B, Rupprecht R, Messer T, Kohnlein O, Dabitz H, Brückl T, Müller N, Pfister H, Lieb R, Müller JC, Lohmussaar E, Strom TM, Bettecken T, Meitinger T, Uhr M, Rein T, Holsboer F, Müller-Myhsok B: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004; 36:1319-1325 (Pubitemid 39577942)
10. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, Tang Y, Gillespie CF, Heim CM, Nemeroff CB, Schwartz AC, Cubells JF, Ressler KJ: Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008; 299:1291-1305 (Pubitemid 351439075)
11. Ising M, Depping AM, Siebertz A, Lucae S, Unschuld PG, Kloiber S, Horstmann S, Uhr M, Müller-Myhsok B, Holsboer F: Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci 2008; 28:389-398
12. Lavebratt C, Aberg E, Sjoholm LK, Forsell Y: Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. J Affect Disord 2010; 125:249-255
13. Lekman M, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ, Paddock S: The FKBP5-gene in depression and treatment response - an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) cohort. Biol Psychiatry 2008; 63:1103-1110
14. Zobel A, Schuhmacher A, Jessen F, Hofels S, von Widdern O, Metten M, Pfeiffer U, Hanses C, Becker T, Rietschel M, Scheef L, Block W, Schild HH, Maier W, Schwab SG: DNA sequence variants of the FKBP5 gene are associated with unipolar depression. Int J Neuropsychopharmacol 2010; 13:649-660
15. Willour VL, Chen H, Toolan J, Belmonte P, Cutler DJ, Goes FS, Zandi PP, Lee RS, Mackinnon DF, Mondimore FM, Schweizer B, DePaulo JR Jr, Gershon ES, McMahon FJ, Potash JB: Family-based association of FKBP5 in bipolar disorder. Mol Psychiatry 2009; 14:261-268
16. Brent D, Melhem N, Ferrell R, Emslie G, Wagner KD, Ryan N, Vitiello B, Birmaher B, Mayes T, Zelazny J, Onorato M, Devlin B, Clarke G, DeBar L, Keller M: Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Am J Psychiatry 2010; 167:190-197
17. Papiol S, Arias B, Gasto C, Gutierrez B, Catalan R, Fananas L: Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment. J Affect Disord 2007; 104:83-90 (Pubitemid 350052308)
18. Moffitt TE, Caspi A, Rutter M: Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry 2005; 62:473-481 (Pubitemid 40637222)
19. Roy A, Gorodetsky E, Yuan Q, Goldman D, Enoch MA: Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 2010; 35:1674-1683
20. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Farrer LA, Gelernter J: Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 2010; 35:1684-1692
21. Lieb R, Isensee B, von Sydow K, Wittchen HU: The Early Developmental Stages of Psychopathology Study (EDSP): a methodological update. Eur Addict Res 2000; 6:170-182 (Pubitemid 32008817)
22. Wittchen HU, Perkonigg A, Lachner G, Nelson CB: Early Developmental Stages of Psychopathology Study (EDSP): objectives and design. Eur Addict Res 1998; 4:18-27 (Pubitemid 28163791)
23. Wittchen H-U, Pfister H: DIA-X-Interviews: Manual für Screening- Verfahren und Interview; Interviewheft Längsschnittuntersuchung (DIA-X-Lifetime); Ergänzungsheft (DIA-X-Lifetime); Inter view heft Querschnittuntersuchung (DIA-X-12 Monate); Ergän z ung sheft (DIA-X-12Monate); PC-Programm zur Durchführ ung des Interviews (Längs und Querschnittuntersuchung); Auswertungsprogramm. Frankfurt, Germany, Swets & Zeitlinger, 1997
24. Lachner G, Wittchen HU, Perkonigg A, Holly A, Schuster P, Wunderlich U, Turk D, Garczynski E, Pfister H: Structure, content and reliability of the Munich Composite International Diagnostic Interview (M-CIDI) substance use sections. Eur Addict Res 1998; 4:28-41 (Pubitemid 28163792)
25. Reed V, Gander F, Pfister H, Steiger A, Sonntag H, Trenkwalder C, Hundt W, Wittchen HU: To what degree does the Composite International Diagnostic Interview (CIDI) correctly identify DSM-IV disorders? testing validity issues in a clinical sample. Int J Methods Psychiatr Res 1998; 7:142-155 (Pubitemid 128730061)
26. Wittchen HU: Reliability and validity studies of the WHO Composite International Diagnostic Interview (CIDI) - a critical review. J Psychiatr Res 1994; 28:57-84
27. Stata Statistical Software: Release 9.0. College Station, Tex, Stata Corp, 2005
28. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265 (Pubitemid 40202029)
29. Darroch J: Biologic synergism and parallelism. Am J Epidemiol 1997; 145:661-668
30. Höfler M: Causal inference based on counterfactuals. BMC Med Res Methodol 2005; 5:28
31. Rothman KJ: Epidemiology: An Introduction. New York, Oxford University Press, 2002, p 168
32. Rutter M, Thapar A, Pickles A: Gene-environment interactions - biologically valid pathway or artifact? Arch Gen Psychiatry 2009; 66:1287-1289
33. Greenland S: Basic problems in interaction assessment. Environ Health Perspect 1993; 101:59-66
34. Joffe MM, Greenland S: Standardized estimates from categorical regression models. Stat Med 1995; 14:2131-2141
35. Therneau TM, Grambsch PM: Modeling Survival Data: Extending the Cox Model. New York, Springer, 2000
36. Zimmermann P, Brückl T, Lieb R, Nocon A, Ising M, Beesdo K, Wittchen HU: The interplay of familial depression liability and adverse events in predicting the first onset of depression during a 10-year follow-up. Biol Psychiatry 2008; 63:406-414
37. Polanczyk G, Caspi A, Williams B, Price TS, Danese A, Sugden K, Uher R, Poulton R, Moffitt TE: Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. Arch Gen Psychiatry 2009; 66:978-985
38. Bernstein D, Fink L: Childhood Trauma Questionnaire Manual. San Antonio, Tex, Psychological Corp, 1998
39. Robins LN, Cottler L, Bucholz KK, Compton W: Diagnostic Interview Schedule for DSM-IV. St Louis, Washington University School of Medicine, 1995
40. Kirchheiner J, Lorch R, Lebedeva E, Seeringer A, Roots I, Sasse J, Brockmoller J: Genetic variants in FKBP5 affecting response to antidepressant drug treatment. Pharmacogenomics 2008; 9:841-846
41. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, Valle D, Pulver AE: Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 2005; 77:918-936 (Pubitemid 41698514)
42. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J, Griem A, Kovacs M, Ott J, Merikangas KR: Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009; 301:2462-2471
43. Appelhof BC, Huyser J, Verweij M, Brouwer JP, van Dyck R, Fliers E, Hoogendijk WJ, Tijssen JG, Wiersinga WM, Schene AH: Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression). Biol Psychiatry 2006; 59:696-701
44. Aubry JM, Gervasoni N, Osiek C, Perret G, Rossier MF, Bertschy G, Bondolfi G: The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients. J Psychiatr Res 2007; 41:290-294 (Pubitemid 44854997)
45. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M, Turecki G, Meaney MJ: Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009; 12:342-348